Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 8.74% vs -15.83% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 35.76% vs 5.20% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 28.33% vs -3.60% in Mar 2024
Compare Balance Sheet Results of Oxygenta Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
36.98
35.69
1.29
3.61%
Share Warrants & Outstandings
Total Reserve
-62.01
99.25
-161.26
-162.48%
Shareholder's Funds
-25.02
134.94
-159.96
-118.54%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
21.52
19.21
2.31
12.02%
Secured Loans
2.63
9.72
-7.09
-72.94%
Unsecured Loans
18.89
9.48
9.41
99.26%
Deferred Tax Assets / Liabilities
-10.80
4.25
-15.05
-354.12%
Other Long Term Liabilities
0.00
1.84
-1.84
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.08
0.56
0.52
92.86%
Total Non-Current Liabilities
11.80
25.85
-14.05
-54.35%
Current Liabilities
Trade Payables
29.79
13.83
15.96
115.40%
Other Current Liabilities
15.11
10.69
4.42
41.35%
Short Term Borrowings
40.71
18.72
21.99
117.47%
Short Term Provisions
0.23
1.54
-1.31
-85.06%
Total Current Liabilities
85.85
44.78
41.07
91.72%
Total Liabilities
72.62
205.58
-132.96
-64.68%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
61.50
188.63
-127.13
-67.40%
Less: Accumulated Depreciation
21.87
104.19
-82.32
-79.01%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
39.63
84.44
-44.81
-53.07%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.23
0.20
0.03
15.00%
Intangible assets under development
0.00
1.00
-1.00
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
32.40
-32.35
-99.85%
Long Term Loans & Advances
0.68
21.42
-20.74
-96.83%
Other Non Current Assets
1.08
0.00
1.08
0.00%
Total Non-Current Assets
41.68
139.46
-97.78
-70.11%
Current Assets Loans & Advances
Current Investments
0.00
0.02
-0.02
-100.00%
Inventories
20.51
12.47
8.04
64.47%
Sundry Debtors
5.10
40.45
-35.35
-87.39%
Cash and Bank
0.12
1.32
-1.20
-90.91%
Other Current Assets
4.58
1.83
2.75
150.27%
Short Term Loans and Advances
0.63
10.04
-9.41
-93.73%
Total Current Assets
30.94
66.12
-35.18
-53.21%
Net Current Assets (Including Current Investments)
-54.90
21.33
-76.23
-357.38%
Total Current Assets Excluding Current Investments
30.94
66.10
-35.16
-53.19%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
72.62
205.58
-132.96
-64.68%
Contingent Liabilities
2.91
20.87
-17.96
-86.06%
Total Debt
62.23
37.93
24.30
64.07%
Book Value per share (adjusted)
-6.77
37.81
-44.58
-117.91%
Annual - Borrowings
Borrowings 62.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.74% vs -15.83% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 39.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 35.76% vs 5.20% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 30.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 28.33% vs -3.60% in Mar 2024
